Abstract
THE bcl-2 proto-oncogene is activated by translocation in a variety of B-lymphoid tumours and synergizes with the c-myc oncogene in tumour progression1. The mechanism of synergy is unclear but bcl-2 expression inhibits apoptosis2–6, a property presumably pertinent to its proto-oncogenic mode of action4. We have shown that the c-myc gene is a potent inducer of apoptosis, in addition to its established role in mitogenesis7. Here we show that expression of the bcl-2 protein, Bcl-2, specifically abrogates c-mvoinduced apoptosis without affecting the c-myc mitogenic function. This provides a novel mechanism for oncogene cooperation, of potential importance both in carcinogenesis and in the evolution of drug resistance in tumours.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MYC sensitises cells to apoptosis by driving energetic demand
Nature Communications Open Access 09 August 2022
-
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
Leukemia Open Access 24 July 2021
-
BCL-2 as therapeutic target for hematological malignancies
Journal of Hematology & Oncology Open Access 11 May 2018
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Strasser, A., Harris, A. W., Bath, M. L. & Cory, S. Nature 348, 331–333 (1990).
Vaux, D. L., Cory, S. & Adams, J. M. Nature 335, 440–442 (1988).
Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. & Korsmeyer, S. J. Nature 348, 334–336 (1990).
McDonnell, T. J. & Korsmeyer, S. J. Nature 349, 254–256 (1991).
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O. & Korsmeyer, S. J. Cell 67, 879–888 (1991).
Strasser, A., Harris, A. W. & Cory, S. Cell 67, 889–899 (1991).
Evan, G. I. et al. Cell 63, 119–125 (1992).
Eilers, M., Picard, D., Yamamoto, K. R. & Bishop, M. J. Nature 340, 66–68 (1989).
Eilers, M., Schirm, S. & Bishop, J. M. EMBO J. 10, 133–141 (1991).
Askew, D., Ashmun, R., Simmons, B. & Cleveland, J. Oncogene 6, 1915–1922 (1991).
Pezzella, F. et al. Am. J. Path. 137, 225–232 (1990).
Wyllie, A. H. J. Path. 153, 313–316 (1987).
Bursch, W., Kleine, L. & Tenniswood, M. Biochem. Cell Biol. 68, 1071–1074 (1990).
Lennon, S. V., Martin, S. J. & Cotter, T. G. Biochem. Soc. Trans. 18, 343–345 (1990).
Spencer, C. A. & Groudine, M. Adv. Cancer Res. 56, 1–48 (1991).
Liu, L. F. A. Rev. Biochem. 58, 351–375 (1989).
Land, H., Parada, L. F. & Weinberg, R. A. Nature 304, 596–602 (1983).
Reed, J. C., Haldar, S., Croce, C. M. & Cuddy, M. P. Molec. cell. Biol. 10, 4370–4374 (1990).
Borst, P. Acta oncol. 30, 87–105 (1991).
Morgenstern, J. P. & Land, H. Nucleic Acids Res. 18, 3587–3596 (1990).
Morgenstern, J. & Land, H. in Methods in Molecular Biology (ed. Murray, E.) 181–205 (Humana, Clifton, New Jersey, 1991).
Evan, G. I. & Hancock, D. C. Cell 43, 253–261 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fanidi, A., Harrington, E. & Evan, G. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359, 554–556 (1992). https://doi.org/10.1038/359554a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/359554a0
This article is cited by
-
Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics
Modern Pathology (2022)
-
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
Leukemia (2022)
-
MYC sensitises cells to apoptosis by driving energetic demand
Nature Communications (2022)
-
Emerging connectivity of programmed cell death pathways and its physiological implications
Nature Reviews Molecular Cell Biology (2020)
-
BCL-2 as therapeutic target for hematological malignancies
Journal of Hematology & Oncology (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.